Karen Quillen, MD

Professor, Pathology & Laboratory Medicine

Karen Quillen
617.358.2694
670 Albany St .

Other Positions

  • Member, Evans Center for Interdisciplinary Biomedical Research, Boston University

Education

  • Queen's University, MD
  • Harvard University, AB

Publications

  • Published on 8/31/2021

    Shevtsov A, Parada M, Burks EJ, Quillen K. Peripheral blood smear and hemoglobin electrophoresis of unsuspected hemoglobin Bart's hydrops fetalis in a newborn. Int J Lab Hematol. 2021 Aug 31. PMID: 34464034.

    Read at: PubMed
  • Published on 7/14/2021

    Kritselis M, Yambayev I, Prilutskiy A, Shevtsov A, Vadlamudi C, Zheng H, Elsadwai M, Ma L, Aniskovich E, Kataria Y, Higgins S, Sarita-Reyes C, Zuo T, Zhao Q, Quillen K, Burks EJ. Distinctive pseudopalisaded histiocytic hyperplasia characterizes the transition of exudative to proliferative phase of diffuse alveolar damage in patients dying of COVID-19. Hum Pathol. 2021 10; 116:49-62. PMID: 34273395.

    Read at: PubMed
  • Published on 4/9/2021

    Yuen RR, Steiner D, Pihl RMF, Chavez E, Olson A, Smith EL, Baird LA, Korkmaz F, Urick P, Sagar M, Berrigan JL, Gummuluru S, Corley RB, Quillen K, Belkina AC, Mostoslavsky G, Rifkin IR, Kataria Y, Cappione AJ, Gao W, Lin NH, Bhadelia N, Snyder-Cappione JE. Novel ELISA Protocol Links Pre-Existing SARS-CoV-2 Reactive Antibodies With Endemic Coronavirus Immunity and Age and Reveals Improved Serologic Identification of Acute COVID-19 via Multi-Parameter Detection. Front Immunol. 2021; 12:614676. PMID: 33897682.

    Read at: PubMed
  • Published on 3/1/2021

    Kaufman AR, Quillen K, Distefano AG, Sloan JM. Nonsecretory Recurrence of Multiple Myeloma Presenting as Sixth Nerve Palsy Secondary to Clival Plasmacytoma. J Neuroophthalmol. 2021 03 01; 41(1):e77-e78. PMID: 32235225.

    Read at: PubMed
  • Published on 9/8/2020

    Prilutskiy A, Kritselis M, Shevtsov A, Yambayev I, Vadlamudi C, Zhao Q, Kataria Y, Sarosiek SR, Lerner A, Sloan JM, Quillen K, Burks EJ. SARS-CoV-2 Infection-Associated Hemophagocytic Lymphohistiocytosis. Am J Clin Pathol. 2020 09 08; 154(4):466-474. PMID: 32681166.

    Read at: PubMed
  • Published on 9/1/2020

    Sarosiek S, Zheng L, Sloan JM, Quillen K, Brauneis D, Sanchorawala V. Comparing measures of hematologic response after high-dose melphalan and stem cell transplantation in AL amyloidosis. Blood Cancer J. 2020 09 01; 10(8):88. PMID: 32873776.

    Read at: PubMed
  • Published on 10/4/2019

    Gupta VK, White PS, Brauneis D, Shelton AC, Quillen K, Sanchorawala V, Sarosiek S, Sloan JM. Safety of autologous stem cell transplantation in patients with known Human T-cell Lymphotropic Viruses Type 1 and 2 infection: A case series of four patients. Am J Hematol. 2019 12; 94(12):E317-E319. PMID: 31489689.

    Read at: PubMed
  • Published on 5/9/2019

    Singh P, Chen H, Gordon CE, Ghai S, Sloan JM, Quillen K, Moradi S, Chitalia V, Gautam A, Henderson J, Francis JM. Monoclonal IgG4/2? Deposition Following Eculizumab Therapy for Recurrent Atypical Hemolytic Uremic Syndrome in Kidney Transplantation. Kidney Med. 2019 May-Jun; 1(3):139-143. PMID: 32734194.

    Read at: PubMed
  • Published on 1/21/2019

    Phull P, Sanchorawala V, Brauneis D, Sloan JM, Siddiqi OK, Quillen K, Sarosiek S. High-dose melphalan and autologous peripheral blood stem cell transplantation in patients with AL amyloidosis and cardiac defibrillators. Bone Marrow Transplant. 2019 08; 54(8):1304-1309. PMID: 30664726.

    Read at: PubMed
  • Published on 1/11/2019

    Gupta VK, Brauneis D, Shelton AC, Quillen K, Sarosiek S, Sloan JM, Sanchorawala V. Induction Therapy with Bortezomib and Dexamethasone and Conditioning with High-Dose Melphalan and Bortezomib Followed by Autologous Stem Cell Transplantation for Immunoglobulin Light Chain Amyloidosis: Long-Term Follow-Up Analysis. Biol Blood Marrow Transplant. 2019 05; 25(5):e169-e173. PMID: 30639823.

    Read at: PubMed

View 74 more publications: View full profile at BUMC

View all profiles